
Metabolic Geneticist

No OPD information available
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency
Andersen Disease
Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome)
Orotic Aciduria Type 1
Aspartylglucosaminuria
Brachydactyly Mononen Type
CACH Syndrome
Cardiomyopathy
Carnitine Palmitoyltransferase 1 Deficiency
Carnitine-Acylcarnitine Translocase Deficiency
Cholesteryl Ester Storage Disease
Chronic Pain
Dementia
Enlarged Liver
Gaucher Disease
Glutaric Acidemia Type 2
Hemolytic Disease of the Newborn
Inborn Amino Acid Metabolism Disorder
Infantile Axonal Neuropathy
Kearns-Sayre Syndrome
Krabbe Disease
MELAS Syndrome
Metabolic Acidosis
Mucopolysaccharidoses (MPS)
Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
Mucopolysaccharidosis Type 7 (MPS VII, Sly Syndrome)
Necrosis
Ornithine Transcarbamylase Deficiency
Pantothenate Kinase-Associated Neurodegeneration
Peripheral Neuropathy
Phenylketonuria (PKU)
Pompe Disease
Progressive External Ophthalmoplegia
Pyruvate Decarboxylase Deficiency
Pyruvate Dehydrogenase Deficiency
Rhabdomyolysis
Sideroblastic Anemia
Succinic Semialdehyde Dehydrogenase Deficiency
Urea Cycle Disorders (UCD)
Von Gierke Disease
Wolman Disease
Kaustuv Bhattacharya is a medical professional who helps people with various health conditions. Some of the conditions they specialize in are 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, Andersen Disease, and many others. They are skilled in treating a wide range of disorders like Chronic Pain, Dementia, and Enlarged Liver.
Kaustuv Bhattacharya communicates with patients in a caring and understanding way, which helps patients feel comfortable and trust them. They stay updated with the latest medical knowledge and research to provide the best care possible to their patients. This dedication to learning ensures that patients receive the most effective treatments available.
In their work, Kaustuv Bhattacharya collaborates with other medical professionals to provide comprehensive care for patients. By working together with colleagues, they can offer a multidisciplinary approach to treatment, which leads to better outcomes for patients.
One of Kaustuv Bhattacharya's notable publications is a study on the cost-effectiveness of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer. This research helps guide treatment decisions and improve the quality of care for patients with this type of cancer.
Overall, Kaustuv Bhattacharya's work has had a positive impact on many patients' lives by providing expert care, staying informed about the latest advancements in medicine, and collaborating with other healthcare professionals to deliver comprehensive treatment plans. Their dedication to improving patient outcomes and advancing medical knowledge makes them a trusted and respected healthcare provider in their field.
